Who Gets Coronavirus Vaccine First? – October 2, 2020
Who Gets Coronavirus Vaccine First? – October 2, 2020
On October 2 the U.S. National Academies of Science, Engineering, and Medicine issued its consensus Framework for Equitable Allocation of a COVID-19 Vaccine. William H. Foege, MD, MPH, Emeritus Distinguished Professor of International Health at the Rollins School of Public Health at Emory University, co-chaired the committee that authored the report, and discusses its recommendations. Recorded October 2, 2020.• Earn Free CME credits by watching JAMA Livestreams and completing a brief questionnaire. Claim 0.5 credits for each video at https://ja.ma/covidqa
• Coronavirus Resource page from the JAMA Network: https://ja.ma/covidyt
• To watch all the #JAMALive Q&A's Visit: https://ja.ma/covidqaytpl
• Don't forget to hit subscribe or click https://ja.ma/subscribe
Topics discussed in this interview:
0:00 Introduction
0:54 Helene Gayle and the Gates Foundation
3:52 Framework for Equitable Allocation of a COVID-19 Vaccine
5:16 Ethics and equity in vaccine distribution
8:33 Are health care workers a priority?
10:45 Phase 1
11:28 Cold storage of the vaccine
12:58 Vaccine switching
13:37 Phase 2
15:13 Vaccinating the elderly
18:35 Timeline for an approved vaccine
22:10 Duration of immunity
23:39 The CDC
26:41 Vaccine hesitancy
28:44 President Trump, masks, and COVID-19
30:30 Receiving the Presidential Medal of Freedom
---------------------------------------------------------------------------------
For more from JAMA
• https://www.jama.com
• https://www.facebook.com/JAMAJournal
• https://www.twitter.com/JAMA_Current
• https://www.linkedin.com/company/jamanetwork
Follow the JAMA Network
• https://www.jamanetwork.com
• http://www.jamanetworkaudio.com
• https://www.facebook.com/JAMANetwork
• https://www.twitter.com/JAMANetwork
• https://www.instagram.com/JAMANetwork
• https://www.pinterest.com/JAMANetwork
=====================================================================
#JAMALive #Coronavirus #Pandemic #COVID19 #SARSCoV2
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.